Logo 1 Logo 2

Clinical Trial Details

Trial ID: L0074
Source ID: NCT01029002
Associated Drug: Vitamin D
Title: The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease
Acronym:
Status: COMPLETED
Study Results: YES
Results: https://ClinicalTrials.gov/show/NCT01029002/results
Conditions: Chronic Renal Insufficiency|Proteinuria
Interventions: DRUG: Vitamin D|OTHER: Placebo
Outcome Measures: Primary: Effect of Vitamin D Supplementation on Albuminuria in CKD Patients as Assessed by Urine Albumin/Creatinine Measures., Urine albumin and creatinine were measured on spot urine specimens., 3 months | Secondary: Effect of Repletion Doses of Vitamin D Increase 25(OH) Vitamin D Levels to Above 30 ng/mL in a Multi-ethnic Sample of Patients With CKD as a Secondary Outcome., 25(OH) vitamin D levels were measured using liquid chromatography., 3 months|Effect of Vitamin D Supplementation on Mean Systolic Blood Pressure as Measured by Ambulatory Blood Pressure in CKD Patients as a Secondary Outcome., 3 months
Sponsor/Collaborators: Sponsor: Albert Einstein College of Medicine | Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 74
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Start Date: 2009-10
Completion Date: 2014-06
Results First Posted: 2023-08-16
Last Update Posted: 2023-08-16
Locations: Montefiore medical center, Bronx, New York, 10467, United States
URL: https://clinicaltrials.gov/show/NCT01029002